Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug 14:5:101.
doi: 10.1186/s40814-019-0482-x. eCollection 2019.

An electronic registry to improve adherence to active surveillance monitoring among men with prostate cancer at a safety-net hospital: protocol for a pilot study

Affiliations

An electronic registry to improve adherence to active surveillance monitoring among men with prostate cancer at a safety-net hospital: protocol for a pilot study

Benjamin Cedars et al. Pilot Feasibility Stud. .

Abstract

Background: The evidence-based practice of active surveillance to monitor men with favorable-risk prostate cancer in lieu of initial definitive treatment is becoming more common. However, there are barriers to effective implementation, particularly in low-resource settings. Our goal is to assess the efficacy and feasibility of a health information technology registry for men on active surveillance at a safety-net hospital to ensure patients receive guideline-recommended care.

Methods: We developed an electronic registry for urology clinic staff to monitor men on active surveillance. The health information technology tool was developed using the Systems Engineering Initiative for Patient Safety model and iteratively tailored to the needs of the clinic by engaging providers in a co-design process. We will enroll all men at Zuckerberg San Francisco General Hospital and Trauma Center who choose active surveillance as a treatment strategy. The primary outcomes to be assessed during this non-randomized, pragmatic evaluation are number of days delayed beyond recommended date of follow-up testing, the proportion of men who are lost to follow-up, the cancer stage at active treatment, and the feasibility and acceptability of the clinic-wide intervention with clinic staff. Secondary outcomes include appointment adherence within 30 days of the scheduled date.

Discussion: Use of a customized electronic approach for monitoring men on active surveillance could improve patient outcomes. It may help reduce the number of men lost to follow-up and improve adherence to timely follow-up testing. Evaluating the adoption and efficacy of a customized registry in a safety-net setting may also demonstrate feasibility for implementation in diverse clinical contexts.

Trial registration: ClinicalTrials.gov identifier NCT03553732, An Electronic Registry to Improve Adherence to Active Surveillance Monitoring at a Safety-net Hospital. Registered 11 June 2018.

Keywords: Active surveillance; Health information technology (HIT); Patient safety; Prostate cancer; Safety net; Systems Engineering Initiative for Patient Safety (SEIPS).

PubMed Disclaimer

Conflict of interest statement

Competing interestsThe authors declare they have no competing interests.

Figures

Fig. 1
Fig. 1
Workflow diagram depicting the various elements of the HIT tool
Fig. 2
Fig. 2
a Screenshot depicting the population-level view of patients on AS. The patient names are fictitious for demonstration purposes. b Screenshot of AS follow-up tasks on the patient level

Similar articles

Cited by

References

    1. Hamdy FC, Donovan JL, Lane JA, Mason M, Metcalfe C, Holding P, et al. 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med. 2016;375(15):1415–1424. doi: 10.1056/NEJMoa1606220. - DOI - PubMed
    1. Mohler JL. The 2010 NCCN clinical practice guidelines in oncology on prostate cancer. J Natl Compr Canc Netw. 2010;8(2):145. doi: 10.6004/jnccn.2010.0010. - DOI - PubMed
    1. Cooperberg MR, Carroll PR. Trends in management for patients with localized prostate cancer, 1990-2013. Jama. 2015;314(1):80–82. doi: 10.1001/jama.2015.6036. - DOI - PubMed
    1. Womble PR, Montie JE, Ye Z, Linsell SM, Lane BR, Miller DC. Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer. European urology. 2015;67(1):44–50. doi: 10.1016/j.eururo.2014.08.024. - DOI - PubMed
    1. Loeb S, Walter D, Curnyn C, Gold HT, Lepor H, Makarov DV. How active is active surveillance? Intensity of followup during active surveillance for prostate cancer in the United States. The J Urol. 2016;196(3):721–726. doi: 10.1016/j.juro.2016.02.2963. - DOI - PMC - PubMed

Associated data

LinkOut - more resources